Cargando…

Atorvastatin reduces β-Adrenergic dysfunction in rats with diabetic cardiomyopathy

BACKGROUND: In the diabetic heart the β-adrenergic response is altered partly by down-regulation of the β1-adrenoceptor, reducing its positive inotropic effect and up-regulation of the β3-adrenoceptor, increasing its negative inotropic effect. Statins have clinical benefits on morbidity and mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carillion, Aude, Feldman, Sarah, Na, Na, Biais, Matthieu, Carpentier, Wassila, Birenbaum, Aurélie, Cagnard, Nicolas, Loyer, Xavier, Bonnefont-Rousselot, Dominique, Hatem, Stéphane, Riou, Bruno, Amour, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519044/ https://www.ncbi.nlm.nih.gov/pubmed/28727746 http://dx.doi.org/10.1371/journal.pone.0180103

Ejemplares similares

Diaphragmatic function is enhanced in fatty and diabetic fatty rats
por: De Jong, Audrey, et al.
Publicado: (2017)

Resveratrol and Cardiovascular Diseases
por: Bonnefont-Rousselot, Dominique
Publicado: (2016)

Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes
por: Baeyens, Audrey, et al.
Publicado: (2013)

Beta-Adrenergic Antagonist Tolerance in Amyloid Cardiomyopathy
por: Ramsell, Stuart, et al.
Publicado: (2022)

Translation termination efficiency modulates ATF4 response by regulating ATF4 mRNA translation at 5′ short ORFs
por: Ait Ghezala, Hayet, et al.
Publicado: (2012)

Homogeneous Inflammatory Gene Profiles Induced in Human Dermal Fibroblasts in Response to the Three Main Species of Borrelia burgdorferi sensu lato
por: Meddeb, Mariam, et al.
Publicado: (2016)

Use of Resveratrol Self-Emulsifying Systems in T/C28a2 Cell Line as Beneficial Effectors in Cellular Uptake and Protection Against Oxidative Stress-Mediated Death
por: Le Clanche, Solenn, et al.
Publicado: (2018)

Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models
por: Beffagna, Giorgia, et al.
Publicado: (2020)

Evaluation of a semi-automatic isoelectric focusing method for apolipoprotein E phenotyping
por: Bittar, Randa, et al.
Publicado: (2019)

Recurrent Stress Cardiomyopathy During COPD Exacerbation: Are Beta-adrenergic Agonists Only to Blame?
por: Katsa, Ioanna, et al.
Publicado: (2017)

Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
por: Cheignon, C., et al.
Publicado: (2017)

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
por: Grinberg-Bleyer, Yenkel, et al.
Publicado: (2010)

The kinetic glomerular filtration rate is not interchangeable with measured creatinine clearance for prediction of piperacillin underexposure in critically ill patients with augmented renal clearance
por: Carrié, Cédric, et al.
Publicado: (2018)

An Alpha-1A Adrenergic Receptor Agonist Prevents Acute Doxorubicin Cardiomyopathy in Male Mice
por: Montgomery, Megan D., et al.
Publicado: (2017)

Adrenergic cardiomyopathy and cardiogenic shock as initial presentation of pheochromocytoma. A case report and review of the literature
por: Gil-Barrionuevo, Esther, et al.
Publicado: (2018)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

Diagnosis of chylous abdominal effusions: what is the triglyceride threshold value?
por: Lefrère, Bertrand, et al.
Publicado: (2023)

Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study
por: Bielecka-Dąbrowa, Agata, et al.
Publicado: (2010)

Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model
por: Dormoi, Jérôme, et al.
Publicado: (2013)

Atorvastatin-induced pancreatitis
por: Prajapati, Samir, et al.
Publicado: (2010)

Atorvastatin (Lipitor) by MCR
por: Zarganes-Tzitzikas, Tryfon, et al.
Publicado: (2019)

Clinical study of different doses of atorvastatin combined with febuxostat in patients with gout and carotid atherosclerosis
por: Zhang, Zheng, et al.
Publicado: (2020)

Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015)

Computational modeling of Takotsubo cardiomyopathy: effect of spatially varying β-adrenergic stimulation in the rat left ventricle
por: Land, Sander, et al.
Publicado: (2014)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

An extensive β(1)-adrenergic receptor gene signaling network regulates molecular remodeling in dilated cardiomyopathies
por: Tatman, Philip D., et al.
Publicado: (2023)

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage
por: Taoufiq, Zacharie, et al.
Publicado: (2011)

Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine
por: Feldman, David, et al.
Publicado: (2010)

SARS-CoV-2 vaccination efficacy on hospitalisation and variants
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Efficacité vaccinale sur les hospitalisations liées au COVID-19 et les variants()
por: Rozencwajg, Sacha, et al.
Publicado: (2021)

Adrenergic Neurotransmission
por: Roth, Robert H.
Publicado: (1969)

Adrenergic Inhibition with Dexmedetomidine to Treat Stress Cardiomyopathy during Alcohol Withdrawal: A Case Report and Literature Review
por: Harris, Zachary M., et al.
Publicado: (2016)

Atorvastatin-induced acute pancreatitis
por: Deshpande, Prasanna R., et al.
Publicado: (2011)

Bioenhancing effects of naringin on atorvastatin
por: Sama, Venkatesh, et al.
Publicado: (2019)

Atorvastatin-Induced Refractory Thrombocytopenia
por: Ghuman, Jasmine, et al.
Publicado: (2021)

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy – 5-year follow-up
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2013)

Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
por: Jia, Weikun, et al.
Publicado: (2021)

Atorvastatin Treatment for Carotid Intima-Media Thickness in Chinese Patients With Type 2 Diabetes: A Meta-Analysis
por: Fang, Na, et al.
Publicado: (2015)

Screening of coronary microvascular dysfunction in cardiomyopathy of myotonic muscular dystrophy type 1
por: Djaileb, Loic, et al.
Publicado: (2021)

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS)
por: Livingstone, Shona J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1hbhcng8sfdob7ffb5300udk27